ACRX-100

ACRX-100 · Juventas Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ACRX-100, covering 2012-06-06 to 2012-06-06. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Safety of a Single Escalating Dose of ACRX-100 in Adults With Ischemic Heart Failure [Phase 1]

See pricing